Home | Login | Contact Us
Technology Available for Licensing
Browse through a variety of
technologies available for licensing
The SMARTT Network Technologies section fosters early-stage business and technology activity in Western Wisconsin.
- Existing businesses can utilize technology to innovate or expand their product lines.
- Entrepreneurs can use existing technology to build or grow a new business venture without having to incur the R&D costs associated with early-stage technology.
These technologies listed on the SMARTT Network have been proven and are ready for commercialization, thanks to a partnership with the Center for Advanced Technology and Innovation (CATI). Licensing agreements are available by contacting SMARTT Network staff.
Want to list your available technology here?
If you have a technology that is available for licensing, the SMARTT Network can help you market it by listing it here. Please contact the SMARTT Network staff for details.
Off the Shelf - Networking event
If you'd like to speak with others who are interested in early-stage technologies and new product development, or if you want to connect with people who may have expertise that you're seeking, join us at Off the Shelf, a free networking event for proven innovators in Western Wisconsin.
Check out the Off the Shelf Blog
Featured: Sterol Metabolism Enzymes
Technology Owner: Delaware Economic Development Center Ken Anderson
Filed under Bio-Agriculture category
Description of Technology: This invention is in the field of plant molecular biology. More specifically, this invention pertains to nucleic acid fragments encoding sterol metabolism enzymes in plants and seeds.
Patent Listing:
Market Potential: Conversion of 7-dehydrocholesterol to cholesterol is the last reaction in the cholesterol biosynthesis pathway catalyzed by the microsomal enzyme 7-dehydrocholesterol-delta 7 reductase (EC 1.3.1.21). Inhibiting the last step in cholesterol biosynthesis profoundly reduces tissue and plasma cholesterol concentrations and accumulates precursors that substantially slow hepatoma growth. Inhibiting late cholesterol synthesis also hinders the growth of rapidly enlarging malignant tumors (Xu, G. et al. (1996) Hepatology 24:440-445). Analyses of the cDNA encoding the human delta 7 sterol reductase shows that this enzyme is a membrane-bound protein containing 6 to 9 putative transmembrane segments and is structurally related to plant and yeast sterol reductases. The delta 7 sterol reductase is absent from yeast. Microsomes from Saccharomyces cerevisiae strains heterologously expressing the human delta 7 reductase cDNA remove the C7-8 double bond in 7-dehydrocholesterol in a NADPH-dependent manner (Moebius, F. F. et al. (1998) Proc. Natl. Acad. Sci. USA 95:1899-1902).
Benefits:
- § Slows the growth pace of hepatoma and some tumors
Applications:
- Plant molecular biology
